146 related articles for article (PubMed ID: 10770475)
1. Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression.
DeBattista C; Solvason HB; Breen JA; Schatzberg AF
J Clin Psychopharmacol; 2000 Apr; 20(2):274-5. PubMed ID: 10770475
[No Abstract] [Full Text] [Related]
2. Pramipexole in treatment-resistant depression: a 16-week naturalistic study.
Lattanzi L; Dell'Osso L; Cassano P; Pini S; Rucci P; Houck PR; Gemignani A; Battistini G; Bassi A; Abelli M; Cassano GB
Bipolar Disord; 2002 Oct; 4(5):307-14. PubMed ID: 12479663
[TBL] [Abstract][Full Text] [Related]
3. Pramipexole: augmentation in the treatment of depressive symptoms.
Gupta S; Vincent JL; Frank B
CNS Spectr; 2006 Mar; 11(3):172-5. PubMed ID: 16575373
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of pramipexole and sertraline in the forced swimming test.
Maj J; Rogóz Z
Pol J Pharmacol; 1999; 51(6):471-5. PubMed ID: 10817524
[TBL] [Abstract][Full Text] [Related]
5. Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression.
Goldberg JF; Burdick KE; Endick CJ
Am J Psychiatry; 2004 Mar; 161(3):564-6. PubMed ID: 14992985
[TBL] [Abstract][Full Text] [Related]
6. Comparison of pramipexole, fluoxetine, and placebo in patients with major depression.
Corrigan MH; Denahan AQ; Wright CE; Ragual RJ; Evans DL
Depress Anxiety; 2000; 11(2):58-65. PubMed ID: 10812530
[TBL] [Abstract][Full Text] [Related]
7. Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence.
Ciraulo DA; Sarid-Segal O; Knapp CM; Ciraulo AM; LoCastro J; Bloch DA; Montgomery MA; Leiderman DB; Elkashef A
Addiction; 2005 Mar; 100 Suppl 1():12-22. PubMed ID: 15730346
[TBL] [Abstract][Full Text] [Related]
8. Serotonin syndrome induced by augmentation of SSRI with methylphenidate.
Ishii M; Tatsuzawa Y; Yoshino A; Nomura S
Psychiatry Clin Neurosci; 2008 Apr; 62(2):246. PubMed ID: 18412855
[No Abstract] [Full Text] [Related]
9. Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder.
Papakostas GI; Petersen TJ; Nierenberg AA; Murakami JL; Alpert JE; Rosenbaum JF; Fava M
J Clin Psychiatry; 2004 Feb; 65(2):217-21. PubMed ID: 15003076
[TBL] [Abstract][Full Text] [Related]
10. Pramipexole in treatment-resistant depression: an extended follow-up.
Cassano P; Lattanzi L; Soldani F; Navari S; Battistini G; Gemignani A; Cassano GB
Depress Anxiety; 2004; 20(3):131-8. PubMed ID: 15549689
[TBL] [Abstract][Full Text] [Related]
11. Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial.
Perry EB; Berman RM; Sanacora G; Anand A; Lynch-Colonese K; Charney DS
J Clin Psychiatry; 2004 Feb; 65(2):238-43. PubMed ID: 15003079
[TBL] [Abstract][Full Text] [Related]
12. Compulsive Masturbation With Pramipexole for Antidepressant Augmentation in Major Depression: A Case Report.
Rocha FL; Hara C
J Clin Psychopharmacol; 2015 Aug; 35(4):484-5. PubMed ID: 26066339
[No Abstract] [Full Text] [Related]
13. Pramipexole for depression.
Ostow M
Am J Psychiatry; 2002 Feb; 159(2):320-1. PubMed ID: 11823287
[No Abstract] [Full Text] [Related]
14. Forced titration as a confound in an SSRI comparator study of sertaline versus citalopram in the treatment of major depressive disorder.
Burt T; Lane RM
Biol Psychiatry; 2001 Jul; 50(1):66-8. PubMed ID: 11478291
[No Abstract] [Full Text] [Related]
15. Mechanism of synergistic action following co-treatment with pramipexole and fluoxetine or sertraline in the forced swimming test in rats.
Rogóz Z; Skuza G
Pharmacol Rep; 2006; 58(4):493-500. PubMed ID: 16963794
[TBL] [Abstract][Full Text] [Related]
16. Pramipexole ameliorates neurologic and psychiatric symptoms in a Westphal variant of Huntington's disease.
Bonelli RM; Niederwieser G; Diez J; Gruber A; Költringer P
Clin Neuropharmacol; 2002; 25(1):58-60. PubMed ID: 11852299
[TBL] [Abstract][Full Text] [Related]
17. Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression.
Russell JM; Koran LM; Rush J; Hirschfeld RM; Harrison W; Friedman ES; Davis S; Keller M
Depress Anxiety; 2001; 13(1):18-27. PubMed ID: 11233456
[TBL] [Abstract][Full Text] [Related]
18. Clinical Experience With High-Dosage Pramipexole in Patients With Treatment-Resistant Depressive Episodes in Unipolar and Bipolar Depression.
Fawcett J; Rush AJ; Vukelich J; Diaz SH; Dunklee L; Romo P; Yarns BC; Escalona R
Am J Psychiatry; 2016 Feb; 173(2):107-11. PubMed ID: 26844792
[No Abstract] [Full Text] [Related]
19. Treatment of depressive symptoms in Parkinson's disease.
Barone P
Eur J Neurol; 2011 Mar; 18 Suppl 1():11-5. PubMed ID: 21255198
[TBL] [Abstract][Full Text] [Related]
20. Pramipexole for bipolar II depression: a placebo-controlled proof of concept study.
Zarate CA; Payne JL; Singh J; Quiroz JA; Luckenbaugh DA; Denicoff KD; Charney DS; Manji HK
Biol Psychiatry; 2004 Jul; 56(1):54-60. PubMed ID: 15219473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
